Pioneer Group Responds to Parliamentary Findings with New Insights into UK Innovation Economy
New parliamentary scrutiny of the UK’s innovation landscape has reinforced longstanding concerns about how investment in innovation is distributed across the country, with Pioneer Group, a specialist in technology infrastructure and venture building, urging swift...
Alceus Bio Awarded Pioneer Group and AbbVie’s Golden Ticket
Pioneer Group, a specialist in life science infrastructure and venture building, and global biopharmaceutical company AbbVie, have crowned Alceus Bio the winner of their 2025 Golden Ticket programme. The initiative is designed to support breakthrough scientific...
Pioneer and AbbVie Team up on a Golden Ticket to Accelerate Game-Changing Innovations in Human Health
Pioneer Group and AbbVie have teamed up to launch a 2025 Golden Ticket Programme. Pioneer Group, a specialist in life science infrastructure and venture building, has once again teamed up with global biopharmaceutical company AbbVie to launch a Golden Ticket programme...
Pioneer and Novo Nordisk crown Melio Bio winner of 2025 Golden Ticket Programme
Melio Bio, a biotech dedicated to the discovery and development of novel inhibitors targeting a receptor implicated in obesity and associated co-morbidities, has been revealed as the winner of Pioneer Group and Novo Nordisk’s 2025 Golden Ticket Programme. The 2025...
Pioneer Group Appoints Chris Walters as Portfolio Director and European Acquisitions Lead
Pioneer Group has appointed Chris Walters, as Portfolio Director and European Acquisitions Lead. Chris brings extensive experience in life sciences real estate, supported by a strong network of relationships across academia, research institutes, public...
